These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 37721569)
1. Integrating bulk-seq and single-cell-seq reveals disulfidptosis potential index associating with neuroblastoma prognosis and immune infiltration. Zhu A; Li X; Wang J J Cancer Res Clin Oncol; 2023 Dec; 149(18):16647-16658. PubMed ID: 37721569 [TBL] [Abstract][Full Text] [Related]
2. Construction of a novel disulfidptosis-related signature for improving outcomes in hepatocellular carcinoma: Observational study. Chen X; Liang Q; Zhou Y Medicine (Baltimore); 2023 Oct; 102(40):e35423. PubMed ID: 37800779 [TBL] [Abstract][Full Text] [Related]
3. Molecular subtypes of disulfidptosis-regulated genes and prognosis models for predicting prognosis, tumor microenvironment infiltration, and therapeutic response in hepatocellular carcinoma. Qu J; Guan H; Zheng Q; Sun F Int J Biol Macromol; 2024 Mar; 261(Pt 1):129584. PubMed ID: 38246443 [TBL] [Abstract][Full Text] [Related]
4. Role of disulfidptosis in colorectal adenocarcinoma: implications for prognosis and immunity. Yang R; Lai C; Huang L; Li F; Peng W; Wu M; Xin J; Lu Y; Ouyang M; Bai Y; Lei H; He S; Lin Y Front Immunol; 2024; 15():1409149. PubMed ID: 39399504 [TBL] [Abstract][Full Text] [Related]
5. Disulfidptosis classification of hepatocellular carcinoma reveals correlation with clinical prognosis and immune profile. Wang T; Guo K; Zhang D; Wang H; Yin J; Cui H; Wu W Int Immunopharmacol; 2023 Jul; 120():110368. PubMed ID: 37247499 [TBL] [Abstract][Full Text] [Related]
6. A novel prognostic signature and immune microenvironment characteristics associated with disulfidptosis in papillary thyroid carcinoma based on single-cell RNA sequencing. Liao Z; Cheng Y; Zhang H; Jin X; Sun H; Wang Y; Yan J Front Cell Dev Biol; 2023; 11():1308352. PubMed ID: 38033866 [No Abstract] [Full Text] [Related]
7. Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which Xu K; Zhang Y; Yan Z; Wang Y; Li Y; Qiu Q; Du Y; Chen Z; Liu X Front Immunol; 2023; 14():1205250. PubMed ID: 37426643 [TBL] [Abstract][Full Text] [Related]
8. Investigating the prognostic value of constructing disulfidptosis-related gene models for lung adenocarcinoma patients. Luo M; Liu RZ; Li YJ; Zhang SD; Wu ZY Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9569-9585. PubMed ID: 37916324 [TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of disulfidptosis-related immune genes signature to boost the efficacy of prognostic prediction in gastric cancer. Li J; Yu T; Sun J; Ma M; Zheng Z; He Y; Kang W; Ye X Cancer Cell Int; 2024 Mar; 24(1):112. PubMed ID: 38528532 [TBL] [Abstract][Full Text] [Related]
10. Integrated machine learning-driven disulfidptosis profiling: CYFIP1 and EMILIN1 as therapeutic nodes in neuroblastoma. Mengzhen Z; Xinwei H; Zeheng T; Nan L; Yang Y; Huirong Y; Kaisi F; Xiaoting D; Liucheng Y; Kai W J Cancer Res Clin Oncol; 2024 Mar; 150(3):109. PubMed ID: 38427078 [TBL] [Abstract][Full Text] [Related]
11. Disulfidptosis-related gene Zhu J; Ge H; Chen Y; Zhang S; Wu J; Nai W; Min L Transl Cancer Res; 2024 Sep; 13(9):5064-5072. PubMed ID: 39430814 [TBL] [Abstract][Full Text] [Related]
12. Single-cell sequencing and bulk RNA data reveal the tumor microenvironment infiltration characteristics of disulfidptosis related genes in breast cancer. Chen Y; Jin C; Cui J; Diao Y; Wang R; Xu R; Yao Z; Wu W; Li X J Cancer Res Clin Oncol; 2023 Oct; 149(13):12145-12164. PubMed ID: 37428249 [TBL] [Abstract][Full Text] [Related]
13. The disulfidptosis-related signature predicts prognosis and immune features in glioma patients. Wang X; Yang J; Yang F; Mu K Sci Rep; 2023 Oct; 13(1):17988. PubMed ID: 37864127 [TBL] [Abstract][Full Text] [Related]
14. Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies. Liu T; Ren Y; Wang Q; Wang Y; Li Z; Sun W; Fan D; Luan Y; Gao Y; Yan Z Cancer Cell Int; 2023 Nov; 23(1):259. PubMed ID: 37919768 [TBL] [Abstract][Full Text] [Related]
15. Pancancer analysis reveals the role of disulfidptosis in predicting prognosis, immune infiltration and immunotherapy response in tumors. Huang J; Xu Z; Chen D; Zhou C; Shen Y Medicine (Baltimore); 2023 Dec; 102(52):e36830. PubMed ID: 38206694 [TBL] [Abstract][Full Text] [Related]
16. Identification a unique disulfidptosis classification regarding prognosis and immune landscapes in thyroid carcinoma and providing therapeutic strategies. Feng Z; Zhao Q; Ding Y; Xu Y; Sun X; Chen Q; Zhang Y; Miao J; Zhu J J Cancer Res Clin Oncol; 2023 Oct; 149(13):11157-11170. PubMed ID: 37347261 [TBL] [Abstract][Full Text] [Related]
17. The role of molecular subtypes and immune infiltration characteristics based on disulfidptosis-associated genes in lung adenocarcinoma. Qi C; Ma J; Sun J; Wu X; Ding J Aging (Albany NY); 2023 Jun; 15(11):5075-5095. PubMed ID: 37315289 [TBL] [Abstract][Full Text] [Related]
18. Multi-omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple-negative breast cancer. Xie J; Deng X; Xie Y; Zhu H; Liu P; Deng W; Ning L; Tang Y; Sun Y; Tang H; Cai M; Xie X; Zou Y MedComm (2020); 2024 Mar; 5(3):e502. PubMed ID: 38420162 [TBL] [Abstract][Full Text] [Related]
19. Pan-cancer genetic analysis of disulfidptosis-related gene set. Liu H; Tang T Cancer Genet; 2023 Nov; 278-279():91-103. PubMed ID: 37879141 [TBL] [Abstract][Full Text] [Related]
20. Prognosis stratification of patients with breast invasive carcinoma based on cysteine metabolism-disulfidptosis affinity. Zhang Y; Ye Y; Xu A; Luo Y; Sun Y; Zhang W; Ji L J Cancer Res Clin Oncol; 2023 Oct; 149(13):11979-11994. PubMed ID: 37422541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]